Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology
Abstract Background Duchenne muscular dystrophy (DMD) is a fatal muscle‐wasting disorder caused by genetic loss of dystrophin protein. Extracellular microRNAs (ex‐miRNAs) are putative, minimally invasive biomarkers of DMD. Specific ex‐miRNAs (e.g. miR‐1, miR‐133a, miR‐206, and miR‐483) are highly up...
Saved in:
Main Authors: | Tirsa L.E. vanWestering (Author), Yulia Lomonosova (Author), Anna M.L. Coenen‐Stass (Author), Corinne A. Betts (Author), Amarjit Bhomra (Author), Margriet Hulsker (Author), Lucy E. Clark (Author), Graham McClorey (Author), Annemieke Aartsma‐Rus (Author), Maaike vanPutten (Author), Matthew J.A. Wood (Author), Thomas C. Roberts (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
To dystrophin and beyond: an interview with Louis Kunkel
by: Louis M. Kunkel, et al.
Published: (2020) -
Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
by: Annemieke Aartsma-Rus
Published: (2022) -
The use of genetically humanized animal models for personalized medicine approaches
by: Annemieke Aartsma-Rus, et al.
Published: (2020) -
Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function
by: Junling Zhao, et al.
Published: (2019) -
Long-term Exon Skipping Studies With 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models
by: Christa L Tanganyika-de Winter, et al.
Published: (2012)